	Impact of feature harmonization on radiogenomics analysis: Prediction of EGFR and KRAS mutations from non-small cell lung cancer PET/CT images. Comput Biol Med Shiri I, Amini M, Nazari M, Hajianfar G, Haddadi Avval A, Abdollahi H, Oveisi M, Arabi H, Rahmim A, Zaidi H. PMID: 35051856 [PubMed - as supplied by publisher]
	Reducing number of target lesions for RECIST1.1 to predict survivals in patients with advanced non-small-cell lung cancer undergoing anti-PD1/PD-L1 monotherapy. Lung Cancer He LN, Chen T, Fu S, Chen C, Jiang Y, Zhang X, Du W, Li H, Wang Y, Ali WAS, Zhou Y, Lin Z, Yang Y, Huang Y, Zhao H, Fang W, Zhang L, Hong S. PMID: 35051754 [PubMed - as supplied by publisher]
	Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer. Cancer Treat Res Commun Lin SH, Lin HY, Verma V, Xu-Welliver M, Thall PF, Yao L, Kim PY, Gombos DS, Kawedia JD, Komaki R, Gomez DR, Nguyen QN, O'Reilly MS, Lu C, Fossella FV, Skoulidis F, Zhang J, Tsao AS, Heymach JV, Blumenschein GR. PMID: 35051703 [PubMed - as supplied by publisher]
	Clonal Hematopoiesis in Late-Stage Non-Small-Cell Lung Cancer and Its Impact on Targeted Panel Next-Generation Sequencing. JCO Precis Oncol Yaung SJ, Fuhlbrück F, Peterson M, Zou W, Palma JF, Patil NS, Jiang Y. PMID: 35050787 [PubMed - as supplied by publisher]
	Palbociclib in Patients With Non-Small-Cell Lung Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO Precis Oncol Ahn ER, Mangat PK, Garrett-Mayer E, Halabi S, Dib EG, Haggstrom DE, Alguire KB, Calfa CJ, Cannon TL, Crilley PA, Gaba AG, Marr AS, Sangal A, Thota R, Antonelli KR, Islam S, Rygiel AL, Bruinooge SS, Schilsky RL. PMID: 35050752 [PubMed - as supplied by publisher]
	Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non-Small-Cell Lung Cancer With Rare or Complex Mutational Profiles. JCO Precis Oncol Koopman B, van der Wekken AJ, Ter Elst A, Hiltermann TJN, Vilacha JF, Groves MR, van den Berg A, Hiddinga BI, Hijmering-Kappelle LBM, Stigt JA, Timens W, Groen HJM, Schuuring E, van Kempen LC. PMID: 35050740 [PubMed - as supplied by publisher]
	Glyco disulfide capped gold nanoparticle synthesis: cytotoxicity studies and effects on lung cancer A549 cells. Future Med Chem Adokoh CK, Keter FK, Obuah C, Kinfe HH, Tshikhudo R, Darkwa J. PMID: 35050694 [PubMed - as supplied by publisher]
	Urinary Volatomic Expression Pattern: Paving the Way for Identification of Potential Candidate Biosignatures for Lung Cancer. Metabolites Taunk K, Porto-Figueira P, Pereira JAM, Taware R, da Costa NL, Barbosa R, Rapole S, Câmara JS. PMID: 35050157 [PubMed - as supplied by publisher]
	Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence. Curr Oncol Attili I, Passaro A, Pisapia P, Malapelle U, de Marinis F. PMID: 35049698 [PubMed - as supplied by publisher]
	Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study. Curr Oncol Imai H, Kaira K, Masubuchi K, Minato K. PMID: 35049689 [PubMed - as supplied by publisher]
	Clinicopathologic Features and Molecular Biomarkers as Predictors of Epidermal Growth Factor Receptor Gene Mutation in Non-Small Cell Lung Cancer Patients. Curr Oncol Liu L, Xiong X. PMID: 35049681 [PubMed - as supplied by publisher]
	New Strategies and Combinations to Improve Outcomes in Immunotherapy in Metastatic Non-Small-Cell Lung Cancer. Curr Oncol Corke L, Sacher A. PMID: 35049678 [PubMed - as supplied by publisher]
	Diagnostic value of microRNA-148/152 family in non-small-cell lung cancer (NSCLC): A systematic review and meta-analysis. Medicine (Baltimore) Cheng L, Li Q, Tan B, Ma D, Du G. PMID: 35049226 [PubMed - as supplied by publisher]
	New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB-III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes. Thorac Cancer Kameyama K, Imai K, Ishiyama K, Takashima S, Kuriyama S, Atari M, Ishii Y, Kobayashi A, Takahashi S, Kobayashi M, Harata Y, Sato Y, Motoyama S, Hashimoto M, Nomura K, Minamiya Y. PMID: 35048499 [PubMed - as supplied by publisher]
	Lung cancer with PET/CT-defined occult nodal metastasis yields favourable prognosis and benefits from adjuvant therapy: a multicentre study. Eur J Nucl Med Mol Imaging Deng J, Zhong Y, Wang T, Yang M, Ma M, Song Y, She Y, Chen C, MultiomIcs claSSIfier for pulmOnary Nodules (MISSION) Collaborative Group.. PMID: 35048154 [PubMed - as supplied by publisher]
	Cloud-Based Lung Tumor Detection and Stage Classification Using Deep Learning Techniques. Biomed Res Int Kasinathan G, Jayakumar S. PMID: 35047635 [PubMed - in process]
	Long Non-Coding RNAs in Lung Cancer: The Role in Tumor Microenvironment. Front Cell Dev Biol Dai S, Liu T, Liu YY, He Y, Liu T, Xu Z, Wang ZW, Luo F. PMID: 35047506 [PubMed]
	Comprehensive Analysis of Immune Implication and Prognostic Value of IFI44L in Non-Small Cell Lung Cancer. Front Oncol Zeng Y, Zhang Z, Chen H, Fan J, Yuan W, Li J, Zhou S, Liu W. PMID: 35047409 [PubMed]
	Deciphering the Immune-Tumor Interplay During Early-Stage Lung Cancer Development via Single-Cell Technology. Front Oncol Chen WW, Liu W, Li Y, Wang J, Ren Y, Wang G, Chen C, Li H. PMID: 35047383 [PubMed]
	Influence of Psychological Factors in Breast and Lung Cancer Risk - A Systematic Review. Front Psychol Pereira MA, Araújo A, Simões M, Costa C. PMID: 35046872 [PubMed]

Articles 1 - 20 / 121858

Page 1 of 6093



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy